GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ViroGates A/S (OCSE:VIRO) » Definitions » Net Margin %

ViroGates A/S (OCSE:VIRO) Net Margin % : -234.11% (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is ViroGates A/S Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. ViroGates A/S's Net Income for the three months ended in Mar. 2024 was kr-3.60 Mil. ViroGates A/S's Revenue for the three months ended in Mar. 2024 was kr1.54 Mil. Therefore, ViroGates A/S's net margin for the quarter that ended in Mar. 2024 was -234.11%.

The historical rank and industry rank for ViroGates A/S's Net Margin % or its related term are showing as below:

OCSE:VIRO' s Net Margin % Range Over the Past 10 Years
Min: -524.76   Med: -229.72   Max: -63.47
Current: -171.56


OCSE:VIRO's Net Margin % is ranked worse than
81.45% of 814 companies
in the Medical Devices & Instruments industry
Industry Median: -0.41 vs OCSE:VIRO: -171.56

ViroGates A/S Net Margin % Historical Data

The historical data trend for ViroGates A/S's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ViroGates A/S Net Margin % Chart

ViroGates A/S Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial -524.76 -349.94 -214.17 -63.47 -173.12

ViroGates A/S Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -269.66 -231.21 -81.31 -198.03 -234.11

Competitive Comparison of ViroGates A/S's Net Margin %

For the Medical Devices subindustry, ViroGates A/S's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ViroGates A/S's Net Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ViroGates A/S's Net Margin % distribution charts can be found below:

* The bar in red indicates where ViroGates A/S's Net Margin % falls into.



ViroGates A/S Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

ViroGates A/S's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-12.096/6.987
=-173.12 %

ViroGates A/S's Net Margin for the quarter that ended in Mar. 2024 is calculated as

Net Margin=Net Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-3.596/1.536
=-234.11 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ViroGates A/S  (OCSE:VIRO) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


ViroGates A/S Net Margin % Related Terms

Thank you for viewing the detailed overview of ViroGates A/S's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


ViroGates A/S (OCSE:VIRO) Business Description

Traded in Other Exchanges
N/A
Address
Banevaenget 13, Birkerod, DNK, DK-3460
ViroGates A/S is a life science company that develops and sells prognostic products to the healthcare sector. The products are used in hospital emergency services, in particular, to make a clinical decision on hospitalization or discharge of emergency patients. The products can also be used for the prognosis of lifestyle-related diseases such as cardiovascular disease, type 2 diabetes, and cancer. It has developed a product line called suPARnostic to make the suPAR test available as a commercially available test and the ambition is to get the test implemented and used for clinical decision-making.

ViroGates A/S (OCSE:VIRO) Headlines

No Headlines